No risk adjustment or risk stratification

This measure identifies pregnant women who had a HBsAg (hepatitis B) test during their pregnancy.

This measure identifies pregnant women who had an HIV test during their pregnancy.

This measure identifies pregnant women who had a syphilis test during their pregnancy.

The percentage of deliveries of live births between November 6 of the year prior to the measurement year and November 5 of the measurement year. For these women, the measure assesses the following facets of prenatal and postpartum care:
Rate 1: Timeliness of Prenatal Care. The percentage of deliveries that received a prenatal care visit as a member of the organization in the first trimester or within 42 days of enrollment in the organization.
Rate 2: Postpartum Care. The percentage of deliveries that had a postpartum visit on or between 21 and 56 days after delivery.

Percentage of D-negative, unsensitized patients who gave birth during a 12-month period who received anti-D immune globulin at 26-30 weeks gestation.

Percentage of patients who gave birth during a 12-month period who were screened for blood group antibodies during the first or second prenatal care visit.

Percentage of patients who gave birth during a 12-month period who had a determination of blood group (ABO) and D (Rh) type by the second prenatal care visit.

Percentage of deliveries in the measurement period in which women received influenza and tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccinations.

Percentage of patients who gave birth during a 12-month period who were screened for HIV infection during the first or second prenatal care visit.

Percent of patients aged 18 years and older undergoing isolated CABG who received beta blockers within 24 hours preceding surgery.